|
Market Closed -
TEL AVIV STOCK EXCHANGE
11:44:52 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1,020.00 ILa | 0.00% |
|
-1.35% | -6.76% |
| Market Cap | 116M 11.64B 37.1M 33.26M 30.61M 27.67M 51.79M 3.52B 52.78M 364M 146M 1.85B 139M 136M 5.84B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 244M 24.44B 77.89M 69.82M 64.26M 58.09M 109M 7.4B 111M 764M 307M 3.89B 292M 286M 12.27B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -1.35% | ||
| Current month | -8.85% | ||
| 1 month | -8.93% | ||
| 3 months | -6.59% | ||
| 6 months | -11.23% | ||
| Current year | -6.76% |
| 1 week | 1,012 |  | 1,050 |
| 1 month | 1,012 | | 1,209 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,679 |
| 5 years | 1,006 | | 2,566 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 23/08/1993 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 31/10/2018 |
| President | 80 | 27/06/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 24/06/2010 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 80 | 14/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.35% | -13.04% | -38.26% | 37.43M | |
| +3.19% | +8.48% | +74.25% | +153.03% | 1,224B | |
| -0.73% | +2.09% | +46.41% | +87.64% | 662B | |
| +1.41% | +3.40% | +30.98% | +112.26% | 514B | |
| +0.42% | +2.88% | +54.92% | +69.67% | 388B | |
| +2.18% | +1.55% | +72.70% | +45.42% | 361B | |
| +1.12% | +3.80% | +35.82% | +59.72% | 302B | |
| +6.96% | +7.55% | +11.15% | +37.89% | 271B | |
| +1.15% | +4.19% | +59.72% | +78.16% | 249B | |
| +3.06% | +8.58% | +44.03% | +122.76% | 205B | |
| Average | +1.65% | +2.20% | +41.69% | +72.83% | 417.69B | |
| Weighted average by Cap. | +1.19% | +3.04% | +53.35% | +100.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 32.17B 103M 91.89M 84.57M 76.45M 143M 9.73B 146M 1.01B 404M 5.12B 385M 377M 16.15B | 301M 30.1B 95.91M 85.97M 79.12M 71.53M 134M 9.11B 136M 941M 378M 4.79B 360M 352M 15.11B |
| Net income | 6.21M 621M 1.98M 1.77M 1.63M 1.47M 2.76M 188M 2.81M 19.41M 7.8M 98.74M 7.42M 7.26M 312M | -18.07M -1.81B -5.76M -5.16M -4.75M -4.3M -8.04M -547M -8.19M -56.52M -22.71M -288M -21.61M -21.15M -907M |
| Net Debt | 127M 12.71B 40.5M 36.3M 33.41M 30.2M 56.53M 3.84B 57.61M 397M 160M 2.02B 152M 149M 6.38B | 128M 12.8B 40.79M 36.56M 33.65M 30.42M 56.94M 3.87B 58.03M 400M 161M 2.04B 153M 150M 6.43B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ILA 1,020.00 | 0.00% | 10 |
| 29/10/26 | ILA 1,020.00 | 0.00% | 758 |
| 28/10/26 | ILA 1,020.00 | 0.00% | 10 |
| 26/10/26 | ILA 1,020.00 | -0.58% | 1,100 |
| 23/10/26 | ILA 1,026.00 | -0.77% | 2,831 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
